Vitamin D and chronic kidney disease
Open Access
- 1 January 2014
- journal article
- review article
- Published by Korean Association of Internal Medicine in The Korean Journal of Internal Medicine
- Vol. 29 (4), 416-427
- https://doi.org/10.3904/kjim.2014.29.4.416
Abstract
Chronic kidney disease (CKD) has been recognized as a significant global health problem because of the increased risk of total and cardiovascular morbidity and mortality. Vitamin D deficiency or insufficiency is common in patients with CKD, and serum levels of vitamin D appear to have an inverse correlation with kidney function. Growing evidence has indicated that vitamin D deficiency may contribute to deteriorating renal function, as well as increased morbidity and mortality in patients with CKD. Recent studies have suggested that treatment with active vitamin D or its analogues can ameliorate renal injury by reducing fibrosis, apoptosis, and inflammation in animal models; this treatment also decreases proteinuria and mortality in patients with CKD. These renoprotective effects of vitamin D treatment are far beyond its classical role in the maintenance of bone and mineral metabolism, in addition to its pleiotropic effects on extra-mineral metabolism. In this review, we discuss the altered metabolism of vitamin D in kidney disease, and the potential renoprotective mechanisms of vitamin D in experimental and clinical studies. In addition, issues regarding the effects of vitamin D treatment on clinical outcomes are discussed.Keywords
This publication has 89 references indexed in Scilit:
- Paricalcitol Attenuates 4-Hydroxy-2-Hexenal-Induced Inflammation and Epithelial-Mesenchymal Transition in Human Renal Proximal Tubular Epithelial CellsPLOS ONE, 2013
- Beyond proteinuria: VDR activation reduces renal inflammation in experimental diabetic nephropathyAmerican Journal of Physiology-Renal Physiology, 2012
- Vitamin D Therapy and Cardiac Structure and Function in Patients With Chronic Kidney DiseaseJAMA, 2012
- Preventing progression of cardiac hypertrophy and development of heart failure by paricalcitol therapy in ratsCardiovascular Research, 2011
- Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trialThe Lancet, 2010
- Vitamin D DeficiencyThe New England Journal of Medicine, 2007
- Therapeutic role and potential mechanisms of active Vitamin D in renal interstitial fibrosisThe Journal of Steroid Biochemistry and Molecular Biology, 2007
- Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patientsKidney International, 2006
- Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: A longitudinal studyKidney International, 2006
- Transcription factor-κB (NF-κB) and renal diseaseKidney International, 2001